These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10765124)

  • 1. Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas.
    Ferreri AJ; Dell'Oro S; Reni M; Ceresoli GL; Cozzarini C; Ponzoni M; Villa E
    Oncology; 2000 Apr; 58(3):219-26. PubMed ID: 10765124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary diffuse large B-cell lymphoma of the tonsil: is a higher radiotherapy dose required?
    Laskar S; Bahl G; Muckaden MA; Nair R; Gupta S; Bakshi A; Gujral S; Shet T; Shrivastava SK; Dinshaw KA
    Cancer; 2007 Aug; 110(4):816-23. PubMed ID: 17582622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
    Phan J; Mazloom A; Medeiros LJ; Zreik TG; Wogan C; Shihadeh F; Rodriguez MA; Fayad L; Fowler N; Reed V; Horace P; Dabaja BS
    J Clin Oncol; 2010 Sep; 28(27):4170-6. PubMed ID: 20713859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma with Post-Chemotherapy Complete Remission.
    Li Q; Li W; Wang L; Wang W; Niu S; Bi X; Wang H; Zhang Y
    PLoS One; 2015; 10(7):e0133469. PubMed ID: 26193661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging.
    Dorth JA; Prosnitz LR; Broadwater G; Diehl LF; Beaven AW; Coleman RE; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):762-7. PubMed ID: 22420972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum.
    Nguyen LN; Ha CS; Hess M; Romaguera JE; Manning JT; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1281-5. PubMed ID: 10889382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
    Todeschini G; Secchi S; Morra E; Vitolo U; Orlandi E; Pasini F; Gallo E; Ambrosetti A; Tecchio C; Tarella C; Gabbas A; Gallamini A; Gargantini L; Pizzuti M; Fioritoni G; Gottin L; Rossi G; Lazzarino M; Menestrina F; Paulli M; Palestro M; Cabras MG; Di Vito F; Pizzolo G
    Br J Cancer; 2004 Jan; 90(2):372-6. PubMed ID: 14735179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant radiotherapy to an initial bulky mass in diffuse large B-cell lymphoma: lack of survival benefit.
    Tomita N; Kodama F; Motomura S; Itoh S; Ohshima R; Hyo R; Kawano T; Hashimoto C; Takemura S; Yamazaki E; Fujita H; Fujisawa S; Ogawa K; Kanamori H; Ishigatsubo Y
    Int J Lab Hematol; 2008 Feb; 30(1):53-7. PubMed ID: 18190468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome.
    Avilés A; Fernándezb R; Pérez F; Nambo MJ; Neri N; Talavera A; Castañeda C; González M; Cleto S
    Leuk Lymphoma; 2004 Jul; 45(7):1385-9. PubMed ID: 15359637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity.
    Hoppe BS; Moskowitz CH; Filippa DA; Moskowitz CS; Kewalramani T; Zelenetz AD; Yahalom J
    J Clin Oncol; 2008 Apr; 26(11):1858-64. PubMed ID: 18332466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma.
    Avilés A; Delgado S; Nambo MJ; Alatriste S; Díaz-Maqueo JC
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):799-803. PubMed ID: 7525515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
    Pfreundschuh M; Ho AD; Cavallin-Stahl E; Wolf M; Pettengell R; Vasova I; Belch A; Walewski J; Zinzani PL; Mingrone W; Kvaloy S; Shpilberg O; Jaeger U; Hansen M; Corrado C; Scheliga A; Loeffler M; Kuhnt E;
    Lancet Oncol; 2008 May; 9(5):435-44. PubMed ID: 18400558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of differing radiotherapy strategies on treatment results in diffuse large-cell lymphoma: a review.
    Nieder C; Licht T; Andratschke N; Peschel C; Molls M
    Cancer Treat Rev; 2003 Feb; 29(1):11-9. PubMed ID: 12633576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional survival benefit of involved-lesion radiation therapy after R-CHOP chemotherapy in limited stage diffuse large B-cell lymphoma.
    Kwon J; Kim IH; Kim BH; Kim TM; Heo DS
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):91-8. PubMed ID: 25721091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases].
    Tchen N; Eghbali H; Soubeyran P; Trojani M; Richaud P; Bonnel C; Quénel-Tueux N; Hoerni B
    Bull Cancer; 1997 Jul; 84(7):704-8. PubMed ID: 9339196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma.
    Xu LM; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Liu QF; Chen B; Qi SN; Ren H; Dai JR
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1289-95. PubMed ID: 23245279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary non-Hodgkin's lymphoma of the paranasal sinuses: a report of 14 cases].
    Su ZY; Zhang DS; Zhu MQ; Shi YX; Jiang WQ
    Ai Zheng; 2007 Aug; 26(8):919-22. PubMed ID: 17697560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients.
    Bekkenk MW; Vermeer MH; Geerts ML; Noordijk EM; Heule F; van Voorst Vader PC; van Vloten WA; Meijer CJ; Willemze R
    J Clin Oncol; 1999 Aug; 17(8):2471-8. PubMed ID: 10561311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.